HIGHBRIDGE CAPITAL MANAGEMENT LLC - PHOENIX BIOTECH ACQUISITION ownership

PHOENIX BIOTECH ACQUISITION's ticker is and the CUSIP is 71902K113. A total of 52 filers reported holding PHOENIX BIOTECH ACQUISITION in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
HIGHBRIDGE CAPITAL MANAGEMENT LLC ownership history of PHOENIX BIOTECH ACQUISITION
ValueSharesWeighting
Q3 2023$51,182
+17.4%
714,8270.0%0.00%0.0%
Q2 2023$43,604
+311357.1%
714,827
+23.7%
0.00%
+100.0%
Q1 2023$14
-33.3%
577,844
+16.7%
0.00%0.0%
Q4 2022$21
-99.9%
495,194
-26.4%
0.00%0.0%
Q3 2022$38,000
-56.8%
672,608
-0.7%
0.00%
-50.0%
Q2 2022$88,000
-4.3%
677,408
+60.5%
0.00%0.0%
Q1 2022$92,000
-53.5%
422,033
-6.2%
0.00%
-50.0%
Q4 2021$198,000449,6960.00%
Other shareholders
PHOENIX BIOTECH ACQUISITION shareholders Q4 2022
NameSharesValueWeighting ↓
MANGROVE PARTNERS IM, LLC 163,538$1,746,5860.12%
Q Global Advisors, LLC 170,785$70.01%
Atalaya Capital Management LP 225,000$9,0000.00%
MMCAP International Inc. SPC 375,000$15,0000.00%
Segantii Capital Management Ltd 5,000$53,4000.00%
DIFESA CAPITAL MANAGEMENT, LP 62,500$2,5060.00%
PERISCOPE CAPITAL INC. 957,098$38,3010.00%
Sage Rock Capital Management LP 91,999$3,6890.00%
Castle Creek Arbitrage, LLC 200,000$8,0000.00%
Context Capital Management, LLC 200,000$80.00%
View complete list of PHOENIX BIOTECH ACQUISITION shareholders